AD |
Alzheimer’s Disease |
ALS |
Amyotrophic Lateral Sclerosis |
BDNF |
Brain Derived Neurotrophic Factor |
bFGF |
Basic Fibroblast Growth Factor |
CD |
Cluster of Differentiation |
c-Myc |
Cellular Myelocytomatosis Oncogene |
CNTF |
Ciliary Neurotrophic Factor |
ECM |
Extracellular Matrix |
EGF |
Epidermal Growth Factor |
ESC |
Embryonic Stem Cells |
FTD |
Frontotemporal Dementia |
GDNF |
Glial Cell-Derived Neurotrophic Factor |
Glis1 |
Glis Family Zinc Finger 1 |
HD |
Huntington’s Disease |
iPSCs |
Induced Pluripotent Stem Cells |
Klf4 |
Kruppel-Like factor 4 |
LAA |
L-Ascorbic Acid |
LD |
Linear Dichroism |
MNs |
Motor Neurons |
MNDs |
Motor Neuron Disease |
NDs |
Neurodegenerative Disease |
NEAA |
Non-Essential Amino Acids |
NPCs |
Neural Precursor Cells |
NT-3 |
Neurotrophin 3 |
Oct4 |
Octamer Bunding Transcription Factor 4 |
OSKM |
Group of Reprogramming Factors: Oct4, Sox2, Klf4, c-Myc |
PD |
Parkinson’s Disease |
PI3K |
Phosphoinositide 3-Kinase |
PS48 |
Allosteric Phosphoinositide-Dependent Protein Kinase 2 (PDK1) |
RA |
Retinoic Acid |
SAG |
Smoothened Agonist |
SCA |
Spinocerebral Ataxia |
SCNT |
Somatic Cell Nuclear Transfer |
SCs |
Stem Cells |
SHH |
Sonic Hedgehog Signaling Molecule |
SMA |
Spinal Muscular Atrophy |
SNPs |
Small Nuclear Polymorphisms |
Sox2 |
SRY (Sex Determining Region Y)-box 2 |
SSEA4 |
Stage-specific Embryonic Antigen 4 |
TFs |
Transcription Factor |
TRA-1-81 |
Tumor-Related Antigen 1-81 |
TRA-1-60 |
Tumor-Related Antigen 1-60 |
TSA |
Trichostatin A |
VPA |
Valproic acid |